hERG1 and HIF-2α Behave as Biomarkers of Positive Response to Bevacizumab in Metastatic Colorectal Cancer Patients()

Background: In search of novel biomarkers of response to bevacizumab in metastatic colorectal cancer (mCRC), we analyzed the expression and prognostic role of several proteins related to angiogenesis. Methods: A retrospective, multicenter study on 80 surgical samples from mCRC patients treated in fi...

Descripción completa

Detalles Bibliográficos
Autores principales: Iorio, Jessica, Lastraioli, Elena, Tofani, Lorenzo, Petroni, Giulia, Antonuzzo, Lorenzo, Messerini, Luca, Perrone, Giuseppe, Caputo, Damiano, Francesconi, Maria, Amato, Maria Michelina, Cadei, Moris, Arcangeli, Giuseppina, Villanacci, Vincenzo, Boni, Luca, Coppola, Roberto, Di Costanzo, Francesco, Arcangeli, Annarosa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2020
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044526/
https://www.ncbi.nlm.nih.gov/pubmed/32105990
http://dx.doi.org/10.1016/j.tranon.2020.01.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044526/
https://www.ncbi.nlm.nih.gov/pubmed/32105990
http://dx.doi.org/10.1016/j.tranon.2020.01.001

Ejemplares similares